References
- Smith TJ, Hegedüs L. Graves’ disease. N Engl J Med. 2016;375(16):1552–1565.
- Barnett PS, McGregor AM. Immunological factors. Disease of the thyroid: pathophysiology and management. In: Wheeler MH, Lazarus JH, editors. Cambridge (UK): Chapman & Hall Medical; 1994. p. 85–103.
- Tomer Y. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol Mech Dis. 2014;9(1):147–156.
- Brix TH, Kyvik KO, Christensen K, et al. Evidence for a major role of heredity in Graves’ disease: a population based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001;86(2):930–934.
- Kahaly GJ, Petrak F, Hardt J, et al. Psychosocial morbidity of Graves’ orbitopathy. Clin Endocrinol. 2005;63(4):395–402.
- Brandt F, Almind D, Christensen K, et al. Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a Danish nationwide register-based cohort study of twins and singletons. J Clin Endocrinol Metab. 2012;97(11):4123–4129.
- Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286–295.
- Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves’ disease. Trend Endocrinol Metab. 2005;16(5):243–248.
- Subekti I. Diagnosis Dan Pengelolaan Oftalmopati Graves. Jakarta Endocrinology Meeting, Divisi Metabolik Endokrinologi, Departemen Ilmu Penyakit Dalam FKUI/RSCM, Jakarta; 2008. p. 30–35.
- Koutras DA. Disturbances of menstruation in thyroid disease. Ann NY Acad Sci. 1997;816(1 Adolescent Gy):280–284.
- Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–1236.
- Homburg R. Polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2008;22(2):261–274.
- Sen A, Kushnir VA, Barad DH, et al. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol. 2014;10(1):37–50.
- van Gelderen CJ, Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med. 1993;38(5):381–386.
- Hefler-Frischmuth K, Walch K, Huebl W, et al. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril. 2010;93(7):2291–2294.
- McGrogan A, Seaman HE, Wright JW, et al. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf). 2008;69(5):687–696.
- Glintborg D, Rubin KH, Nybo M, et al. Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study. Endocr Connect. 2019;8(10):1405–1415.
- Goi R, Matsuda M, Maekawa H, et al. Two cases of Hashimoto’s thyroiditis with transient hypothyroidism. Intern Med. 1992;31(1):64–68.
- Jung JH, Hahm JR, Jung TS, et al. A 27-year-old woman diagnosed as polycystic ovary syndrome associated with Graves’ disease. Intern Med. 2011;50(19):2185–2189.
- Tong C, Wang Y-H, Yu H-C, et al. Increased risk of polycystic ovary syndrome in Taiwanese women with chronic periodontitis: a nationwide population-based retrospective cohort study. J Womens Health. 2019;28(10):1436–1441.
- Tellez M, Cooper J, Edmonds C. Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol. 1992;36(3):291–294.
- Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150:363–369.
- Takasu N, Yamada T, Sato A, et al. Graves’ disease following hypothyroidism due to Hashimoto’s disease: studies of eight cases. Clin Endocrinol (Oxf). 1990;33(6):687–698.
- Krassas GE, Pontikides N, Kaltsas T, et al. Menstrual disturbances in thyrotoxicosis. Clin Endocrinol. 1994;40(5):641–644.
- Redmond GP. Thyroid dysfunction and women’s reproductive health. Thyroid. 2004;14(supplement 1):S5–S15.
- Reimand K, Talja I, Metskula K, et al. Autoantibody studies of female patients with reproductive failure. J Reprod Immunol. 2001;51(2):167–176.
- Nisar S, Shah PA, Shafi Kuchay M, et al. Association of polycystic ovary syndrome and Graves’ disease: is autoimmunity the link between the two diseases. Indian J Endocr Metab. 2012;16(6):982.
- Szczuko M, Zapałowska-Chwyc’ M, Drozd A, et al. Effect of IGF-I and TNF-a on intensification of steroid pathways in women with PCOS phenotypes are not identical. Enhancement of progesterone pathway in women with PCOS increases the concentration of TNF-a. Gynecol Endocrinol. 2016;32(9):714–717.
- Kim SJ, Heo KG, Shin HY, et al. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke. 2010;41(1):173–176.
- Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15.
- Lua ACY, How CH, King TFJ. Managing polycystic ovary syndrome in primary care. SMEDJ. 2018;59(11):567–571.